London: Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
The Competition and Markets Authority also fined Flynn Pharma 5.2 million pounds for its role in hiking prices of phenytoin sodium capsules in 2012.
Pfizer used to market the medicine itself, under the brand name Epanutin, but sold the rights to Flynn in September 2012, after which the product was debranded and the price soared.
($1 = 0.7903 pounds)
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
The Competition and Markets Authority also fined Flynn Pharma 5.2 million pounds for its role in hiking prices of phenytoin sodium capsules in 2012.
Pfizer used to market the medicine itself, under the brand name Epanutin, but sold the rights to Flynn in September 2012, after which the product was debranded and the price soared.
© Thomson Reuters 2016
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Advertisement
COMMENTS
Advertisement
Pfizer Pauses Gene Therapy Trial For Muscle Disease After Death Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill 'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab Rahul Gandhi's Seat At Red Fort Triggers Fresh Congress Attack On BJP 2 French Rafale Jets Collide Mid-Air, Instructor, Pilot Missing "Pivotal Moment": Key Doctor Body Resumes Strike 2 Days After Calling It Off "Education No More Affordable:" Bengaluru Man Reacts To Rs 3.7 Lakh LKG Fee Woman Shares Series Of Harassment Incidents On Delhi-NCR Streets 1 Arrested In Connection To "Friends" Actor Matthew Perry's Death: Report Track Latest News Live on NDTV.com and get news updates from India and around the world.